ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile

 

Repros Therapeutics Inc. 

2408 Timberloch Place
Suite B-7
The Woodlands  Texas  77380  U.S.A.
Phone: 281-719-3400 Fax: 281-719-3446


SEARCH JOBS








 Company News
Repros Therapeutics Inc. (RPRX) Announces November 30, 2015 PDUFA Goal Date For New Drug Application 4/15/2015 3:19:07 PM
Repros Therapeutics Inc. (RPRX) Receives Confirmation Of Eligibility For Submission Of A Centralized Marketing Authorization Application To The European Medicines Agency As A New Active Substance 4/7/2015 7:10:26 AM
Repros Therapeutics Inc. (RPRX) Announces Acceptance For Filing Of NDA 4/2/2015 7:04:02 AM
Repros Therapeutics Inc. (RPRX) Reports Fourth Quarter And Year End 2014 Financial Results 3/16/2015 7:56:51 AM
Repros Therapeutics Inc. (RPRX) Submits New Drug Application To FDA For Androxal® 2/2/2015 7:47:27 AM
Repros Therapeutics Inc. (RPRX) Initiates Two Phase 2B Uterine Fibroid Studies 12/30/2014 7:32:20 AM
Repros Therapeutics Inc. (RPRX) Updates Androxal® Global Regulatory Status 12/30/2014 7:30:37 AM
Repros Therapeutics Inc. (RPRX) Confirmed As Sole Owner 12/29/2014 9:46:12 AM
Repros Therapeutics Inc. (RPRX) Reports Third Quarter 2014 Financial Results 11/10/2014 8:02:14 AM
Repros Therapeutics Inc. (RPRX) Holds Constructive Meeting With FDA Regarding Androxal® NDA Filing 11/7/2014 7:36:52 AM
12345678910...